First FDA-approved pancrelipase product may mark new era for providers, patients.
Traynor
Kate
K
D002626:Chemistry, Pharmaceutical; D003550:Cystic Fibrosis / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D017277:Drug Approval; D006801:Humans; D020799:Pancrelipase / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration
D003692:Delayed-Action Preparations; D020799:Pancrelipase